Immune inhibitory receptors: Essential regulators of phagocyte function

European Journal of Immunology

Volumn 41, Issue 3, 2011, Pages 575-587

  Steevels, Tessa A M ^a   Meyaard, Linde ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Immune regulation; Inhibitory receptors; Innate immunity; Neutrophils; Signal transduction

Indexed keywords

CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 1; CD200 RECEPTOR; CD31 ANTIGEN; CD47 ANTIGEN; CHEMOKINE; CYTOKINE; FC RECEPTOR; G PROTEIN COUPLED RECEPTOR; GAMMA INTERFERON; IMMUNE INHIBITORY RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; KILLER CELL ACTIVATING RECEPTOR ASSOCIATED PROTEIN; LIGAND; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; PATTERN RECOGNITION RECEPTOR; PROTEIN KINASE SYK; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE PHOSPHATASE SHP 1; PROTEIN TYROSINE PHOSPHATASE SHP 2; REACTIVE OXYGEN METABOLITE; RECEPTOR; STAT3 PROTEIN; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG; UNINDEXED DRUG;

APOPTOSIS; BACTERIUM; CELL ACTIVATION; CELL ADHESION; CELL FUNCTION; CELL MIGRATION; CHEMOTAXIS; CYTOKINE PRODUCTION; CYTOKINE RELEASE; GRANULOCYTE; GROWTH INHIBITION; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MACROPHAGE; MEDIATOR; MOLECULAR EVOLUTION; MONOCYTE; NEUTROPHIL; NONHUMAN; OXIDATIVE STRESS; PATHOGEN ASSOCIATED MOLECULAR PATTERN; PHAGOCYTE; PHAGOCYTOSIS; PHAGOSOME; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RECEPTOR UPREGULATION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; BACTERIA; CELL MOVEMENT; CYTOKINES; HUMANS; IMMUNITY, INNATE; LIGANDS; MICE; MODELS, IMMUNOLOGICAL; PHAGOCYTES; PHAGOCYTOSIS; REACTIVE OXYGEN SPECIES; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION;

EID: 79951792876     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201041179     Document Type: Review

References (130)

1. Soehnlein, O. and Lindbom, L., Phagocyte partnership during the onset and resolution of inflammation. Nat. Rev. Immunol. 2010. 10: 427-439.
2. Weissmann, G., Smolen, J. E. and Korchak, H. M., Release of inflammatory mediators from stimulated neutrophils. N. Engl. J. Med. 1980. 303: 27-34.
3. Nathan, C. and Ding, A., Nonresolving inflammation. Cell 2010. 140: 871-882.
4. Angus, D. C., Linde-Zwirble, W. T., Lidicker, J., Clermont, G., Carcillo, J. and Pinsky, M. R., Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit. Care Med. 2001. 29: 1303-1310.
5. Vivier, E. and Daeron, M., Immunoreceptor tyrosine-based inhibition motifs. Immunol. Today 1997. 18: 286-291.
6. Sansonetti, P. J., The innate signaling of dangers and the dangers of innate signaling. Nat. Immunol. 2006. 7: 1237-1242.
7. Kharitonenkov, A., Chen, Z., Sures, I., Wang, H., Schilling, J. and Ullrich, A., A family of proteins that inhibit signalling through tyrosine kinase receptors. Nature 1997. 386: 181-186.
8. Newman, P. J., Berndt, M. C., Gorski, J., White, G. C., Lyman, S., Paddock, C. and Muller, W. A., PECAM-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily. Science 1990. 247: 1219-1222.
9. Stockinger, H., Gadd, S. J., Eher, R., Majdic, O., Schreiber, W., Kasinrerk, W., Strass, B. et al., Molecular characterization and functional analysis of the leukocyte surface protein CD31. J. Immunol. 1990. 145: 3889-3897.
10. Simmons, D. L., Walker, C., Power, C. and Pigott, R., Molecular cloning of CD31, a putative intercellular adhesion molecule closely related to carcinoembryonic antigen. J. Exp. Med. 1990. 171: 2147-2152.
11. Kong, X. N., Yan, H. X., Chen, L., Dong, L. W., Yang, W., Liu, Q., Yu, L. X. et al., LPS-induced down-regulation of signal regulatory protein alpha contributes to innate immune activation in macrophages. J. Exp. Med. 2007. 204: 2719-2731.
12. Carrithers, M., Tandon, S., Canosa, S., Michaud, M., Graesser, D. and Madri, J. A., Enhanced susceptibility to endotoxic shock and impaired STAT3 signaling in CD31-deficient mice. Am. J. Pathol. 2005. 166: 185-196.
13. Rui, Y., Liu, X., Li, N., Jiang, Y., Chen, G., Cao, X. and Wang, J., PECAM-1 ligation negatively regulates TLR4 signaling in macrophages. J. Immunol. 2007. 179: 7344-7351.
14. Kong, X. N., Yan, H. X., Chen, L., Dong, L. W., Yang, W., Liu, Q., Yu, L. X. et al., LPS-induced down-regulation of signal regulatory protein {alpha} contributes to innate immune activation in macrophages. J. Exp. Med. 2007. 204: 2719-2731.
15. Snelgrove, R. J., Goulding, J., Didierlaurent, A. M., Lyonga, D., Vekaria, S., Edwards, L., Gwyer, E. et al., A critical function for CD200 in lung immune homeostasis and the severity of influenza infection. Nat. Immunol. 2008. 9: 1074-1083.
16. Rygiel, T. P., Rijkers, E. S., de, R. T., Stolte, E. H., van d, V., Rimmelzwaan, G. F., Boon, L. et al., Lack of CD200 enhances pathological T cell responses during influenza infection. J. Immunol. 2009. 183: 1990-1996.
17. Mukhopadhyay, S., Pluddemann, A., Hoe, J. C., Williams, K. J., Varin, A., Makepeace, K., Aknin, M. L. et al., Immune inhibitory ligand CD200 induction by TLRs and NLRs limits macrophage activation to protect the host from meningococcal septicemia. Cell Host. Microbe 2010. 8: 236-247.
18. Yoshizaki, M., Tazawa, A., Kasumi, E., Sasawatari, S., Itoh, K., Dohi, T., Sasazuki, T. et al., Spatiotemporal regulation of intracellular trafficking of Toll-like receptor 9 by an inhibitory receptor, Ly49Q. Blood 2009. 114: 1518-1527.
19. Munday, J., Kerr, S., Ni, J., Cornish, A. L., Zhang, J. Q., Nicoll, G., Floyd, H. et al., Identification, characterization and leucocyte expression of Siglec-10, a novel human sialic acid-binding receptor. Biochem. J. 2001. 355: 489-497.
20. Chen, G. Y., Tang, J., Zheng, P. and Liu, Y., CD24 and Siglec-10 selectively repress tissue damage-induced immune responses. Science 2009. 323: 1722-1725.
21. Ando, M., Tu, W., Nishijima, K. and Iijima, S., Siglec-9 enhances IL-10 production in macrophages via tyrosine-based motifs. Biochem. Biophys. Res. Commun. 2008. 369: 878-883.
22. Zhang, H., Meng, F., Chu, C. L., Takai, T. and Lowell, C. A., The Src family kinases Hck and Fgr negatively regulate neutrophil and dendritic cell chemokine signaling via PIR-B. Immunity 2005. 22: 235-246.
23. Sasawatari, S., Yoshizaki, M., Taya, C., Tazawa, A., Furuyama-Tanaka, K., Yonekawa, H., Dohi, T. et al., The Ly49Q receptor plays a crucial role in neutrophil polarization and migration by regulating raft trafficking. Immunity 2010. 32: 200-213.
24. Privratsky, J. R., Newman, D. K. and Newman, P. J., PECAM-1: conflicts of interest in inflammation. Life Sci. 2010. 87: 69-82.
25. Dangerfield, J., Larbi, K. Y., Huang, M. T., Dewar, A. and Nourshargh, S., PECAM-1 (CD31) homophilic interaction up-regulates alpha6beta1 on transmigrated neutrophils in vivo and plays a functional role in the ability of alpha6 integrins to mediate leukocyte migration through the perivascular basement membrane. J. Exp. Med. 2002. 196: 1201-1211.
26. Wu, Y., Stabach, P., Michaud, M. and Madri, J. A., Neutrophils lacking platelet-endothelial cell adhesion molecule-1 exhibit loss of directionality and motility in CXCR2-mediated chemotaxis. J. Immunol. 2005. 175: 3484-3491.
27. Kim, S., Poursine-Laurent, J., Truscott, S. M., Lybarger, L., Song, Y. J., Yang, L., French, A. R. et al., Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 2005. 436: 709-713.
28. Von Gunten, S. and Simon, H. U., Sialic acid binding immunoglobulin-like lectins may regulate innate immune responses by modulating the life span of granulocytes. FASEB J. 2006. 20: 601-605.
29. Von Gunten, S., Yousefi, S., Seitz, M., Jakob, S. M., Schaffner, T., Seger, R., Takala, J. et al., Siglec-9 transduces apoptotic and nonapoptotic death signals into neutrophils depending on the proinflammatory cytokine environment. Blood 2005. 106: 1423-1431.
30. Carlin, A. F., Uchiyama, S., Chang, Y. C., Lewis, A. L., Nizet, V. and Varki, A., Molecular mimicry of host sialylated glycans allows a bacterial pathogen to engage neutrophil Siglec-9 and dampen the innate immune response. Blood 2009. 113: 3333-3336.
31. Daigle, I., Yousefi, S., Colonna, M., Green, D. R. and Simon, H. U., Death receptors bind SHP-1 and block cytokine-induced anti-apoptotic signaling in neutrophils. Nat. Med. 2002. 8: 61-67.
32. Singer, B. B., Klaile, E., Scheffrahn, I., Muller, M. M., Kammerer, R., Reutter, W., Obrink, B. et al., CEACAM1 (CD66a) mediates delay of spontaneous and Fas ligand-induced apoptosis in granulocytes. Eur. J. Immunol. 2005. 35: 1949-1959.
33. Yu, Q., Chow, E. M., Wong, H., Gu, J., Mandelboim, O., Gray-Owen, S. D. and Ostrowski, M. A., CEACAM1 (CD66a) promotes human monocyte survival via a phosphatidylinositol 3-kinase- and AKT-dependent pathway. J. Biol. Chem. 2006. 281: 39179-39193.
34. Serhan, C. N., Chiang, N. and Van Dyke, T. E., Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat. Rev. Immunol. 2008. 8: 349-361.
35. Malech, H. L. and Hickstein, D. D., Genetics, biology and clinical management of myeloid cell primary immune deficiencies: chronic granulomatous disease and leukocyte adhesion deficiency. Curr. Opin. Hematol. 2007. 14: 29-36.
36. Steevels, T. A. M., Lebbink, R. J., Westerlaken, G. H. A., Coffer, P. J. and Meyaard, L., Signal inhibitory receptor on leukocytes-1 (SIRL-1) is a novel functional inhibitory immune receptor expressed on human phagocytes. J. Immunol. 2010. 184: 4741-4748.
37. Seiffert, M., Cant, C., Chen, Z., Rappold, I., Brugger, W., Kanz, L., Brown, E. J. et al., Human signal-regulatory protein is expressed on normal, but not on subsets of leukemic myeloid cells and mediates cellular adhesion involving its counterreceptor CD47. Blood 1999. 94: 3633-3643.
38. Jiang, P., Lagenaur, C. F. and Narayanan, V., Integrin-associated protein is a ligand for the P84 neural adhesion molecule. J. Biol. Chem. 1999. 274: 559-562.
39. Oldenborg, P. A., Zheleznyak, A., Fang, Y. F., Lagenaur, C. F., Gresham, H. D. and Lindberg, F. P., Role of CD47 as a marker of self on red blood cells. Science 2000. 288: 2051-2054.
40. Oldenborg, P. A., Gresham, H. D. and Lindberg, F. P., CD47-signal regulatory protein alpha (SIRPalpha) regulates Fcgamma and complement receptor-mediated phagocytosis. J. Exp. Med. 2001. 193: 855-862.
41. Yamao, T., Noguchi, T., Takeuchi, O., Nishiyama, U., Morita, H., Hagiwara, T., Akahori, H. et al., Negative regulation of platelet clearance and of the macrophage phagocytic response by the transmembrane glycoprotein SHPS-1. J. Biol. Chem. 2002. 277: 39833-39839.
42. Jaiswal, S., Jamieson, C. H., Pang, W. W., Park, C. Y., Chao, M. P., Majeti, R., Traver, D. et al., CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis. Cell 2009. 138: 271-285.
43. Freire-de-Lima, C. G., Xiao, Y. Q., Gardai, S. J., Bratton, D. L., Schiemann, W. P. and Henson, P. M., Apoptotic cells, through transforming growth factor-beta, coordinately induce anti-inflammatory and suppress pro-inflammatory eicosanoid and NO synthesis in murine macrophages. J. Biol. Chem. 2006. 281: 38376-38384.
44. Fadok, V. A., Bratton, D. L., Guthrie, L. and Henson, P. M., Differential effects of apoptotic versus lysed cells on macrophage production of cytokines: role of proteases. J. Immunol. 2001. 166: 6847-6854.
45. Rosenblum, M. D., Olasz, E., Woodliff, J. E., Johnson, B. D., Konkol, M. C., Gerber, K. A., Orentas, R. J. et al., CD200 is a novel p53-target gene involved in apoptosis-associated immune tolerance. Blood 2004. 103: 2691-2698.
46. Ravetch, J. V. and Lanier, L. L., Immune inhibitory receptors. Science 2000. 290: 84-89.
47. Yu, C. C., Tsui, H. W., Ngan, B. Y., Shulman, M. J., Wu, G. E. and Tsui, F. W., B and T cells are not required for the viable motheaten phenotype. J. Exp. Med. 1996. 183: 371-380.
48. Yusa, S. and Campbell, K. S., Src homology region 2-containing protein tyrosine phosphatase-2 (SHP-2) can play a direct role in the inhibitory function of killer cell Ig-like receptors in human NK cells. J. Immunol. 2003. 170: 4539-4547.
49. Newman, D. K., Hamilton, C. and Newman, P. J., Inhibition of antigen-receptor signaling by platelet endothelial cell adhesion molecule-1 (CD31) requires functional ITIMs, SHP-2, and p56(lck). Blood 2001. 97: 2351-2357.
50. Zhang, S. Q., Yang, W., Kontaridis, M. I., Bivona, T. G., Wen, G., Araki, T., Luo, J. et al., Shp2 regulates SRC family kinase activity and Ras/Erk activation by controlling Csk recruitment. Mol. Cell 2004. 13: 341-355.
51. Bachelet, I., Munitz, A., Moretta, A., Moretta, L. and Levi-Schaffer, F., The inhibitory receptor IRp60 (CD300a) is expressed and functional on human mast cells. J. Immunol. 2005. 175: 7989-7995.
52. Hua, C. T., Gamble, J. R., Vadas, M. A. and Jackson, D. E., Recruitment and activation of SHP-1 protein-tyrosine phosphatase by human platelet endothelial cell adhesion molecule-1 (PECAM-1). Identification of immunoreceptor tyrosine-based inhibitory motif-like binding motifs and substrates. J. Biol. Chem. 1998. 273: 28332-28340.
53. Zhang, S., Cherwinski, H., Sedgwick, J. D. and Phillips, J. H., Molecular mechanisms of CD200 inhibition of mast cell activation. J. Immunol. 2004. 173: 6786-6793.
54. Yamanashi, Y. and Baltimore, D., Identification of the Abl- and rasGAP-Associated 62 kDa Protein as a Docking Protein, Dok. Cell 1997. 88: 205-211.
55. Kepley, C. L., Taghavi, S., Mackay, G., Zhu, D., Morel, P. A., Zhang, K., Ryan, J. J. et al., Co-aggregation of FcgammaRII with FcepsilonRI on human mast cells inhibits antigen-induced secretion and involves SHIP-Grb2-Dok complexes. J. Biol. Chem. 2004. 279: 35139-35149.
56. Mihrshahi, R., Barclay, A. N. and Brown, M. H., Essential roles for Dok2 and RasGAP in CD200 receptor-mediated regulation of human myeloid cells. J. Immunol. 2009. 183: 4879-4886.
57. Mihrshahi, R. and Brown, M. H., Downstream of tyrosine kinase 1 and 2 play opposing roles in CD200 receptor signaling. J. Immunol. 2010. 185: 7216-7222.
58. Fong, D. C., Malbec, O., Arock, M., Cambier, J. C., Fridman, W. H. and Daeron, M., Selective in vivo recruitment of the phosphatidylinositol phosphatase SHIP by phosphorylated Fc gammaRIIB during negative regulation of IgE-dependent mouse mast cell activation. Immunol. Lett. 1996. 54: 83-91.
59. Pumphrey, N. J., Taylor, V., Freeman, S., Douglas, M. R., Bradfield, P. F., Young, S. P., Lord, J. M. et al., Differential association of cytoplasmic signalling molecules SHP-1, SHP-2, SHIP and phospholipase C-gamma1 with PECAM-1/CD31. FEBS Lett. 1999. 450: 77-83.
60. Aman, M. J., Lamkin, T. D., Okada, H., Kurosaki, T. and Ravichandran, K. S., The inositol phosphatase SHIP inhibits Akt/PKB activation in B cells. J. Biol. Chem. 1998. 273: 33922-33928.
61. Carver, D. J., Aman, M. J. and Ravichandran, K. S., SHIP inhibits Akt activation in B cells through regulation of Akt membrane localization. Blood 2000. 96: 1449-1456.
62. Brauweiler, A. M., Tamir, I. and Cambier, J. C., Bilevel control of B-cell activation by the inositol 5-phosphatase SHIP. Immunol. Rev. 2000. 176: 69-74.
63. Verbrugge, A., Rijkers, E. S. K., De Ruiter, T. and Meyaard, L., Leukocyte-associated Ig-like receptor-1 has SH-2 domain-containing phosphatase-independent function and recruits C-terminal Src kinase. Eur. J. Immmunol. 2006. 36: 190-198.
64. Veillette, A., Thibaudeau, E. and Latour, S., High expression of inhibitory receptor SHPS-1 and its association with protein-tyrosine phosphatase SHP-1 in macrophages. J. Biol. Chem. 1998. 273: 22719-22728.
65. Sayos, J., Martinez-Barriocanal, A., Kitzig, F., Bellon, T. and Lopez-Botet, M., Recruitment of C-terminal Src kinase by the leukocyte inhibitory receptor CD85j. Biochem. Biophys. Res. Commun. 2004. 324: 640-647.
66. Okada, M., Nada, S., Yamanashi, Y., Yamamoto, T. and Nakagawa, H., Csk: a protein-tyrosine kinase involved in regulation of src family kinases. J. Biol. Chem. 1991. 266: 24249-24252.
67. Crocker, P. R., Paulson, J. C. and Varki, A., Siglecs and their roles in the immune system. Nat. Rev. Immunol. 2007. 7: 255-266.
68. Pasquier, B., Launay, P., Kanamaru, Y., Moura, I. C., Pfirsch, S., Ruffie, C., Henin, D. et al., Identification of FcalphaRI as an inhibitory receptor that controls inflammation: dual role of FcRgamma ITAM. Immunity 2005. 22: 31-42.
69. Wang, L., Gordon, R. A., Huynh, L., Su, X., Park Min, K. H., Han, J., Arthur, J. S. et al., Indirect inhibition of Toll-like receptor and type I interferon responses by ITAM-coupled receptors and integrins. Immunity 2010. 32: 518-530.
70. Hamerman, J. A., Tchao, N. K., Lowell, C. A. and Lanier, L. L., Enhanced Toll-like receptor responses in the absence of signaling adaptor DAP12. Nat. Immunol. 2005. 6: 579-586.
71. Hamerman, J. A., Jarjoura, J. R., Humphrey, M. B., Nakamura, M. C., Seaman, W. E. and Lanier, L. L., Cutting edge: inhibition of TLR and FcR responses in macrophages by triggering receptor expressed on myeloid cells (TREM)-2 and DAP12. J. Immunol. 2006. 177: 2051-2055.
72. Long, E. O., Negative signaling by inhibitory receptors: the NK cell paradigm. Immunol. Rev. 2008. 224: 70-84.
73. Akira, S. and Takeda, K., Toll-like receptor signalling. Nat. Rev. Immunol. 2004. 4: 499-511.
74. Lowell, C. A., Src-family kinases: rheostats of immune cell signaling. Mol. Immunol. 2004. 41: 631-643.
75. Henshall, T. L., Jones, K. L., Wilkinson, R. and Jackson, D. E., Src homology 2 domain-containing protein-tyrosine phosphatases, SHP-1 and SHP-2, are required for platelet endothelial cell adhesion molecule-1/CD31-mediated inhibitory signaling. J. Immunol. 2001. 166: 3098-3106.
76. Maeda, A., Kurosaki, M., Ono, M., Takai, T. and Kurosaki, T., Requirement of SH2-containing protein tyrosine phosphatases SHP-1 and SHP-2 for paired immunoglobulin-like receptor B (PIR-B)-mediated inhibitory signal. J. Exp. Med. 1998. 187: 1355-1360.
77. Chen, T., Zimmermann, W., Parker, J., Chen, I., Maeda, A. and Bolland, S., Biliary glycoprotein (BGPa, CD66a, CEACAM1) mediates inhibitory signals. J. Leukoc. Biol. 2001. 70: 335-340.
78. Munitz, A., Bachelet, I., Eliashar, R., Moretta, A., Moretta, L. and Levi-Schaffer, F., The inhibitory receptor IRp60 (CD300a) suppresses the effects of IL-5, GM-CSF, and eotaxin on human peripheral blood eosinophils. Blood 2006. 107: 1996-2003.
79. Moynagh, P. N., TLR signalling and activation of IRFs: revisiting old friends from the NF-kappaB pathway. Trends Immunol. 2005. 26: 469-476.
80. An, H., Hou, J., Zhou, J., Zhao, W., Xu, H., Zheng, Y., Yu, Y. et al., Phosphatase SHP-1 promotes TLR- and RIG-I-activated production of type I interferon by inhibiting the kinase IRAK1. Nat. Immunol. 2008. 9: 542-550.
81. An, H., Zhao, W., Hou, J., Zhang, Y., Xie, Y., Zheng, Y., Xu, H. et al., SHP-2 phosphatase negatively regulates the TRIF adaptor protein-dependent type I interferon and proinflammatory cytokine production. Immunity 2006. 25: 919-928.
82. You, M., Flick, L. M., Yu, D. and Feng, G. S., Modulation of the nuclear factor kappa B pathway by Shp-2 tyrosine phosphatase in mediating the induction of interleukin (IL)-6 by IL-1 or tumor necrosis factor. J. Exp. Med. 2001. 193: 101-110.
83. Anderson, S. K., Ortaldo, J. R. and McVicar, D. W., The ever-expanding Ly49 gene family: repertoire and signaling. Immunol. Rev. 2001. 181: 79-89.
84. Sivori, S., Falco, M., Carlomagno, S., Romeo, E., Soldani, C., Bensussan, A., Viola, A. et al., A novel KIR-associated function: evidence that CpG DNA uptake and shuttling to early endosomes is mediated by KIR3DL2. Blood 2010. 116: 1637-1647.
85. Fassett, M. S., Davis, D. M., Valter, M. M., Cohen, G. B. and Strominger, J. L., Signaling at the inhibitory natural killer cell immune synapse regulates lipid raft polarization but not class I MHC clustering. Proc. Natl. Acad. Sci. USA 2001. 98: 14547-14552.
86. Eriksson, M., Leitz, G., Fallman, E., Axner, O., Ryan, J. C., Nakamura, M. C. and Sentman, C. L., Inhibitory receptors alter natural killer cell interactions with target cells yet allow simultaneous killing of susceptible targets. J. Exp. Med. 1999. 190: 1005-1012.
87. Turnbull, I. R. and Colonna, M., Activating and inhibitory functions of DAP12. Nat. Rev. Immunol. 2007. 7: 155-161.
88. Mocsai, A., Abram, C. L., Jakus, Z., Hu, Y., Lanier, L. L. and Lowell, C. A., Integrin signaling in neutrophils and macrophages uses adaptors containing immunoreceptor tyrosine-based activation motifs. Nat. Immunol. 2006. 7: 1326-1333.
89. Han, C., Jin, J., Xu, S., Liu, H., Li, N. and Cao, X., Integrin CD11b negatively regulates TLR-triggered inflammatory responses by activating Syk and promoting degradation of MyD88 and TRIF via Cbl-b. Nat. Immunol. 2010. 11: 734-742.
90. Nakayama, M., Underhill, D. M., Petersen, T. W., Li, B., Kitamura, T., Takai, T. and Aderem, A., Paired Ig-like receptors bind to bacteria and shape TLR-mediated cytokine production. J. Immunol. 2007. 178: 4250-4259.
91. Carlin, A. F., Chang, Y. C., Areschoug, T., Lindahl, G., Hurtado-Ziola, N., King, C. C., Varki, A. et al., Group B Streptococcus suppression of phagocyte functions by protein-mediated engagement of human Siglec-5. J. Exp. Med. 2009. 206: 1691-1699.
92. Brinkmann, V., Reichard, U., Goosmann, C., Fauler, B., Uhlemann, Y., Weiss, D. S., Weinrauch, Y. et al., Neutrophil extracellular traps kill bacteria. Science 2004. 303: 1532-1535.
93. Slevogt, H., Zabel, S., Opitz, B., Hocke, A., Eitel, J., N'guessan, P. D., Lucka, L. et al., CEACAM1 inhibits Toll-like receptor 2-triggered antibacterial responses of human pulmonary epithelial cells. Nat. Immunol. 2008. 9: 1270-1278.
94. Barclay, A. N. and Hatherley, D., The counterbalance theory for evolution and function of paired receptors. Immunity 2008. 29: 675-678.
95. Cao, H., Lakner, U., de, B. B., Traherne, J. A., Trowsdale, J. and Barrow, A. D., SIGLEC16 encodes a DAP12-associated receptor expressed in macrophages that evolved from its inhibitory counterpart SIGLEC11 and has functional and non-functional alleles in humans. Eur. J. Immunol. 2008. 38: 2303-2315.
96. Minas, K. and Liversidge, J., Is the CD200/CD200 receptor interaction more than just a myeloid cell inhibitory signal? Crit. Rev. Immunol. 2006. 26: 213-230.
97. Lanier, L. L., Face off - the interplay between activating and inhibitory immune receptors. Curr. Opin. Immunol. 2001. 13: 326-331.
98. Abi-Rached, L. and Parham, P., Natural selection drives recurrent formation of activating killer cell immunoglobulin-like receptor and Ly49 from inhibitory homologues. J. Exp. Med. 2005. 201: 1319-1332.
99. Hatherley, D., Cherwinski, H., Moshref, M. and Barclay, A. N., Recombinant CD200 protein does not bind activating proteins closely related to CD200 receptor. J. Immunol. 2005. 175: 2469-2474.
100. Hatherley, D., Graham, S. C., Turner, J., Harlos, K., Stuart, D. I. and Barclay, A. N., Paired receptor specificity explained by structures of signal regulatory proteins alone and complexed with CD47. Mol. Cell 2008. 31: 266-277.
101. Arase, H., Mocarski, E. S., Campbell, A. E., Hill, A. B. and Lanier, L. L., Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 2002. 296: 1323-1326.
102. Wright, G. J., Jones, M., Puklavec, M. J., Brown, M. H. and Barclay, A. N., The unusual distribution of the neuronal/lymphoid cell surface CD200 (OX2) glycoprotein is conserved in humans. Immunology 2001. 102: 173-179.
103. Wright, G. J., Cherwinski, H., Foster-Cuevas, M., Brooke, G., Puklavec, M. J., Bigler, M., Song, Y. et al., Characterization of the CD200 receptor family in mice and humans and their interactions with CD200. J. Immunol. 2003. 171: 3034-3046.
104. Cantoni, C., Bottino, C., Augugliaro, R., Morelli, L., Marcenaro, E., Castriconi, R., Vitale, M. et al., Molecular and functional characterization of IRp60, a member of the immunoglobulin superfamily that functions as an inhibitory receptor in human NK cells. Eur. J. Immmunol. 1999. 29: 3148-3159.
105. Alvarez-Errico, D., Aguilar, H., Kitzig, F., Brckalo, T., Sayos, J. and Lopez-Botet, M., IREM-1 is a novel inhibitory receptor expressed by myeloid cells. Eur. J. Immunol. 2004. 34: 3690-3701.
106. Skubitz, K. M., Campbell, K. D. and Skubitz, A. P., CD66a, CD66b, CD66c, and CD66d each independently stimulate neutrophils. J. Leukoc. Biol. 1996. 60: 106-117.
107. Cassel, D. L., Keller, M. A., Surrey, S., Schwartz, E., Schreiber, A. D., Rappaport, E. F. and McKenzie, S. E., Differential expression of Fc gamma RIIA, Fc gamma RIIB and Fc gamma RIIC in hematopoietic cells: analysis of transcripts. Mol. Immunol. 1993. 30: 451-460.
108. Colonna, M., Navarro, F., Bellon, T., Llano, M., Garcia, P., Samaridis, J., Angman, L. et al., A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J. Exp. Med. 1997. 186: 1809-1818.
109. Fanger, N. A., Cosman, D., Peterson, L., Braddy, S. C., Maliszewski, C. R. and Borges, L., The MHC class I binding proteins LIR-1 and LIR-2 inhibit Fc receptor-mediated signaling in monocytes. Eur. J. Immunol. 1998. 28: 3423-3434.
110. Cella, M., Dohring, C., Samaridis, J., Dessing, M., Brockhaus, M., Lanzavecchia, A. and Colonna, M., A novel inhibitory receptor (ILT3) expressed on monocytes, macrophages, and dendritic cells involved in antigen processing. J. Exp. Med. 1997. 185: 1743-1751.
111. Trowsdale, J., Barten, R., Haude, A., Stewart, C. A., Beck, S. and Wilson, M. J., The genomic context of natural killer receptor extended gene families. Immunol. Rev. 2001. 181: 20-38.
112. Kubagawa, H., Burrows, P. D. and Cooper, M. D., A novel pair of immunoglobulin-like receptors expressed by B cells and myeloid cells. Proc. Natl. Acad. Sci. USA 1997. 94: 5261-5266.
113. Kubagawa, H., Chen, C.-C., Ho, L. H., Shimada, T., Gartland, L., Mashburn, C., Uehara, T. et al., Biochemical nature and cellular distribution of the paired immunoglobulin-like receptors, PIR-A and PIR-B. J. Exp. Med. 1999. 189: 309-317.
114. Blery, M., Kubagawa, H., Chen, C.-C., Vely, F., Cooper, M. D. and Vivier, E., The paired Ig-like receptor PIR-B is an inhibitory receptor that recruits the protein-tyrosine phosphatase SHP-1. Proc. Natl. Acad. Sci. USA 1998. 95: 2446-2451.
115. Takai, T., Paired immunoglobulin-like receptors and their MHC class I recognition. Immunology 2005. 115: 433-440.
116. Meyaard, L., The inhibitory collagen receptor LAIR-1 (CD305). J. Leukoc. Biol. 2008. 83: 799-803.
117. Lebbink, R. J., De Ruiter, T., Kaptijn, G. J. A., Bihan, D. G., Jansen, C. A., Lenting, P. J. and Meyaard, L., Mouse LAIR-1 functions as an inhibitory collagen-binding receptor on immune cells. Int. Immunol. 2007. 19: 1011-1019.
118. Adams, S., van der Laan, L. J. W., Vernon-Wilson, E. F., Renardel de Lavalette, C., Dopp, E. A., Dijkstra, C. D., Simmons, D. L. et al., Signal-regulatory protein is selectively expressed by myeloid and neuronal cells. J. Immunol. 1998. 161: 1853-1859.
119. Fournier, N., Chalus, L., Durand, I., Garcia, E., Pin, J. J., Churakova, T., Patel, S. et al., FDF03, a novel inhibitory receptor of the immunoglobulin superfamily, is expressed by human dendritic and myeloid cells. J. Immunol. 2000. 165: 1197-1209.
120. Mousseau, D. D., Banville, D., L'Abbe, D., Bouchard, P. and Shen, S. H., PILRalpha, a novel immunoreceptor tyrosine-based inhibitory motif-bearing protein, recruits SHP-1 upon tyrosine phosphorylation and is paired with the truncated counterpart PILRbeta. J. Biol. Chem. 2000. 275: 4467-4474.
121. Shiratori, I., Ogasawara, K., Saito, T., Lanier, L. L. and Arase, H., Activation of natural killer cells and dendritic cells upon recognition of a novel CD99-like ligand by paired immunoglobulin-like type 2 receptor. J. Exp. Med. 2004. 199: 525-533.
122. Brinkman-Van der Linden, E. C., Angata, T., Reynolds, S. A., Powell, L. D., Hedrick, S. M. and Varki, A., CD33/Siglec-3 binding specificity, expression pattern, and consequences of gene deletion in mice. Mol. Cell Biol. 2003. 23: 4199-4206.
123. Cornish, A. L., Freeman, S., Forbes, G., Ni, J., Zhang, M., Cepeda, M., Gentz, R. et al., Characterization of siglec-5, a novel glycoprotein expressed on myeloid cells related to CD33. Blood 1998. 92: 2123-2132.
124. Nicoll, G., Ni, J., Liu, D., Klenerman, P., Munday, J., Dubock, S., Mattei, M. G. et al., Identification and characterization of a novel siglec, siglec-7, expressed by human natural killer cells and monocytes. J. Biol. Chem. 1999. 274: 34089-34095.
125. Zhang, J. Q., Nicoll, G., Jones, C. and Crocker, P. R., Siglec-9, a novel sialic acid binding member of the immunoglobulin superfamily expressed broadly on human blood leukocytes. J. Biol. Chem. 2000. 275: 22121-22126.
126. Angata, T., Kerr, S. C., Greaves, D. R., Varki, N. M., Crocker, P. R. and Varki, A., Cloning and characterization of human Siglec-11. A recently evolved signaling molecule that can interact with SHP-1 and SHP-2 and is expressed by tissue macrophages, including brain microglia. J. Biol. Chem. 2002. 277: 24466-24474.
127. Bates, E. E. M., Fournier, N., Garcia, E., Valladeau, J., Durand, I., Pin, J.-J., Zurawski, S. M. et al., APCs express DCIR, a novel C-type lectin surface receptor containing an immunoreceptor tyrosine-based inhibitory motif. J. Immunol. 1999. 163: 1973-1983.
128. Toyama-Sorimachi, N., Tsujimura, Y., Maruya, M., Onoda, A., Kubota, T., Koyasu, S., Inaba, K. et al., Ly49Q, a member of the Ly49 family that is selectively expressed on myeloid lineage cells and involved in regulation of cytoskeletal architecture. Proc. Natl. Acad. Sci. USA 2004. 101: 1016-1021.
129. Marshall, A. S., Willment, J. A., Lin, H. H., Williams, D. L., Gordon, S. and Brown, G. D., Identification and characterization of a novel human myeloid inhibitory C-type lectin-like receptor (MICL) that is predominantly expressed on granulocytes and monocytes. J. Biol. Chem. 2004. 279: 14792-14802.
130. Pyz, E., Huysamen, C., Marshall, A. S., Gordon, S., Taylor, P. R. and Brown, G. D., Characterisation of murine MICL (CLEC12A) and evidence for an endogenous ligand. Eur. J. Immunol. 2008. 38: 1157-1163.